MMIT is regarded as a trusted go-to-market partner that identifies barriers to access and helps coordinate major stakeholders to move therapies from pipeline to patients—answering the “what” of how payers cover therapies and the “why” behind those decisions. MMIT’s product portfolio has been built by listening to our clients, and we’ve been able to do that with expert teams of pharmacists, clinicians, data specialists and market researchers who provide foresight, clarity, and confidence. This is the hallmark of who we are and who we will always be.
More than two decades ago, MMIT (Managed Markets Insight & Technology, LLC) began as a division of Medi-Media, an agency supporting pharmaceutical clients in key areas of commercialization.
In 2016, MMIT acquired Atlantic Information Services (AIS), the creator of the Directory of Health Plans (DHP) and leading healthcare publications. And three years later, MMIT acquired Zitter Health Insights, a provider of market access insights and solutions for specialty drugs with the longest-running, most robust panel of active P&T members to help answer the “why” of market access. That same year, MMIT acquired RJ Health Solutions, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit.
MMIT announced that it would unite with The Dedham Group in May of 2021, the preeminent U.S. market oncology and specialty partner to the pharmaceutical and biotechnology industry. The Dedham Group has leveraged its expertise and industry-leading data platform, Pulse Analytics, to support payer, provider and clinical pathways. And in August of 2021, MMIT merged with Evaluate, a London-based provider of commercial intelligence and predictive analytics to the pharmaceutical industry. The newly merged organization will offer customers a unique and comprehensive data solution offering both analytical and predictive data insights across the entire drug life.
We answer the “what” and the “why” related to drug coverage and reimbursement.
MMIT brings transparency to pharmacy and medical benefit information, partnering with pharmacy benefit managers (PBMs), payers and pharmaceutical manufacturers from pharmacy and therapeutics (P&T) to point of care. We analyze market access trends and market readiness challenges while providing brand and market access solutions to navigate the rapidly changing healthcare market.
We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and fine-tune strategy.
MMIT has been 100% focused on market access for decades. We combine deep domain expertise around drug coverage with innovative technology and trusted data to answer key business questions related to access. MMIT data is trusted by US physicians and sourced through a combination of direct partnerships with payers/PBMs and a technology infrastructure, powered by smart business logic, artificial intelligence and human validation.
Acquired in early 2019, Zitter Insights is a division of MMIT that brings market research and helps address the “why” of market access. Our Zitter Insights panel represents top health plans, PBMs and IDNs to provide meaningful insights to our clients.
AIS Health, acquired in 2016, is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals.
RJ Health Solutions is the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit. RJ expanded our reach while also providing us with the ability to support pricing and coding transparency and strategic reimbursement services for pharma.
Sign up for publications to get unmatched business intelligence delivered to your inbox.